Ozempic has ascended to prominence, heralded as the contemporary elixir for weight reduction. Initially sanctioned by the FDA in 2017 for Type 2 diabetes management, its off-label use as a weight-loss aid has surged, triggering supply scarcities in the United States.
Yet, the pressing inquiry remains: How safe is Ozempic, and does it truly deliver on its lofty promises?
Fitness luminary and certified nutritionist Jillian Michaels offers a critical perspective, asserting Ozempic’s impermanence in the pharmaceutical market. In a dialogue with Sage Steele, Michaels delineated three pivotal points:
Jillian Michaels’ Perspective on Ozempic
1. Plateau Effect
– Inevitable Plateau : According to Jillian Michaels, users will eventually plateau on Ozempic. This is because the drug increases the hormone Glucagon-like peptide 1 (GLP-1), which the body naturally produces to regulate insulin. Over time, the body stops producing this hormone on its own and develops a tolerance.
– Weight Regain : When users stop taking Ozempic, they tend to regain the lost weight, implying dependency on the drug for continuous weight management.
2. Post-Ozempic Effects
– Muscle and Bone Loss : Discontinuing Ozempic can lead to significant muscle loss and compromised bone density. This can result in a slower metabolism.
– Epigenetic Changes : Prolonged low food intake can lower the metabolic set point and potentially affect future generations. Studies suggest that individuals who experienced famine conditions passed on a slower metabolism to their offspring due to biochemical shifts in their bodies.
3. Side Effects
- Gastrointestinal Issues : Common side effects of Ozempic and Wegovy (a drug with the same active ingredient) include vomiting, diarrhea, pain, and nausea.
- Gastroparesis : There is a link between the popular medication Ozempic and a condition where the stomach becomes dangerously paralyzed, known as gastroparesis.
- Facial Changes : Rapid weight loss from taking Ozempic can lead to “global facial wasting,” resulting in wrinkling and heaviness around the eyes, temples, jawline, and mouth, giving a more gaunt appearance.
Jillian Michaels warns of the potential long-term consequences of using Ozempic for weight loss. The drug may lead to an eventual plateau in weight loss, muscle and bone density loss upon discontinuation, and significant gastrointestinal side effects. Additionally, rapid weight loss may cause noticeable changes in facial appearance. While effective in the short term, Ozempic’s long-term safety and efficacy raise concerns, especially regarding the risk of dependency and rebound weight gain.
The Plateau Phenomenon
Michaels unequivocally states, “You will plateau on this drug,” emphasizing it as an incontrovertible truth. Ozempic’s mechanism involves augmenting Glucagon-like peptide 1 (GLP-1), a hormone naturally synthesized by the body to modulate insulin levels. However, exogenous administration of this hormone leads the body to diminish its endogenous production, culminating in the development of drug tolerance.
The Inevitable Rebound
As the physiological efficacy of Ozempic wanes and cessation ensues, Michaels cautions, “You will gain all of the weight back,” signifying a dependency on the drug. This phenomenon is corroborated by extensive meta-analyses, as Michaels urges, “Google it.”
Post-Ozempic Consequences
Dr. Peter Attia, an authority on longevity medicine, has conducted extensive research on the repercussions of discontinuing drugs like Ozempic. His findings reveal alarming rates of muscle atrophy and compromised bone density among individuals who cease its use. Michaels elaborates that this leads to a decelerated metabolism, as the body, deprived of sustenance for extended periods, adjusts its metabolic set point downward.
Moreover, studies indicate that periods of severe caloric restriction induce epigenetic modifications, predisposing subsequent generations to slower metabolisms. Michaels summarizes, “There is a devastating rebound effect when people get off the drugs.”
Conclusion
In essence, while Ozempic may offer a temporary solution, its long-term implications warrant caution. The potential for metabolic disruption and the transgenerational impact underscore the need for a measured approach to its use.
Apex Energetics Glysen-Synergy K-79
Glysen™ (K1), Adaptocrine™ (K2), Fibromin™(K25), and Protoglysen™ (K28) are combined into individually easy-to-use packages.
